Furthermore, given the age dependency of these genetic effects, it will be intriguing to analyse the genetic expression patterns in younger and older patients to ascertain AT1 and AT2 genetic pathways in astrocytomas. This evidence concerns the gene AGTR1 and astrocytoma (excluding glioblastoma).